Mario Hernández-Garibay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mario Hernández-Garibay has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- David Fernández-Quezada
Instituto de Neurociencias Traslacionales, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Sierra Mojada 950, Guadalajara 44340, Mexico
2 shared publications - Joaquín García-Estrada
Instituto de Neurociencias Traslacionales, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Sierra Mojada 950, Guadalajara 44340, Mexico
2 shared publications - Rocio Elizabeth González-Castañeda
Universidad de Guadalajara, Guadalajara, Jalisco MEXICO
2 shared publications - Rosa Yaveth Ruvalcaba-Delgadillo
Laboratorio de Microscopia de Alta Resolución, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Sierra Mojada 950, Guadalajara 44340, Mexico
2 shared publications - Sonia Luquin
Instituto de Neurociencias Traslacionales, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Sierra Mojada 950, Guadalajara 44340, Mexico
2 shared publications - Ulises De la Cruz-Mosso
Red de Inmunonutrición y Genómica Nutricional en las Enfermedades Autoinmunes, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico
2 shared publications
Latest Publications
- Open Access
Effects of Olive Leaf Extract on Anxiety Symptoms and Metainflammation in Women with Excess Weight: A Randomized Double-Blind Placebo-Controlled Pilot Trial
Anxiety symptomatology and excess weight are associated with chronic low-grade inflammation. Olive leaf extract (OLE) contains polyphenols with antioxidant and anti-inflammatory properties that have shown anxiolytic-like effects in experimental models; however, evidence in humans remains limited. This randomized double-blind placebo-controlled pilot trial evaluated the effects of OLE supplementation on anxiety symptomatology, inflammatory markers, and metabolic parameters in women with excess weight and mild to moderate anxiety symptoms. Participants received OLE (750 mg/day) or placebo for 12 weeks. Anxiety symptomatology was assessed using HAM-A, BAI, and STAI, while inflammatory and metabolic parameters were evaluated at baseline and post-intervention. Since the expected sample size was not achieved, our results are preliminary. No effect was observed from OLE supplementation. However, some differences within groups can direct future researchers interested in evaluating these parameters. OLE supplementation correlated with a particular reduction phenotype in anxious symptomatology (HAM-A, BAI and STAI-Trait) with inflammatory (hs-CRP) and metabolic parameters (c-HDL) that may open the possibility of an anti-inflammatory effect. In contrast, the observations in the Pb group seemed more associated with a pro-inflammatory state and a placebo effect related to somatic symptoms of anxiety. These preliminary observations need to be confirmed with larger randomized clinical trials that may help clarify these results and the possible underlying mechanisms.
Open AccessEffects of Olive Leaf Extract on Anxiety Symptoms and Metainflammation in Women with Excess Weight: A Randomized Double-Blind Placebo-Controlled Pilot Trial
Anxiety symptomatology and excess weight are associated with chronic low-grade inflammation. Olive leaf extract (OLE) contains polyphenols with antioxidant and anti-inflammatory properties that have shown anxiolytic-like effects in experimental models; however, evidence in humans remains limited. This randomized double-blind placebo-controlled pilot trial evaluated the effects of OLE supplementation on anxiety symptomatology, inflammatory markers, and metabolic parameters in women with excess weight and mild to moderate anxiety symptoms. Participants received OLE (750 mg/day) or placebo for 12 weeks. Anxiety symptomatology was assessed using HAM-A, BAI, and STAI, while inflammatory and metabolic parameters were evaluated at baseline and post-intervention. Since the expected sample size was not achieved, our results are preliminary. No effect was observed from OLE supplementation. However, some differences within groups can direct future researchers interested in evaluating these parameters. OLE supplementation correlated with a particular reduction phenotype in anxious symptomatology (HAM-A, BAI and STAI-Trait) with inflammatory (hs-CRP) and metabolic parameters (c-HDL) that may open the possibility of an anti-inflammatory effect. In contrast, the observations in the Pb group seemed more associated with a pro-inflammatory state and a placebo effect related to somatic symptoms of anxiety. These preliminary observations need to be confirmed with larger randomized clinical trials that may help clarify these results and the possible underlying mechanisms.
- Open Access
- 18 May 2026
- Published by MDPI AG in Preprints.org
Effects of Olive Leaf Extract on Anxiety Symptoms and Metainflammation in Women with Excess Weight: A Randomized Double-Blind Placebo Controlled Pilot Trial
Anxiety symptomatology and excess weight are associated with chronic low-grade inflammation. Olive Leaf Extract (OLE) contains polyphenols with antioxidant and anti-inflammatory properties that have shown anxiolytic like effects in experimental models; however, evidence in humans remains limited. This randomized double-blind placebo-controlled pilot trial evaluated the effects of OLE supplementation on anxiety symptomatology, inflammatory markers, and metabolic parameters in women with excess weight and mild to moderate anxiety symptoms. Participants received OLE (750 mg/day) or placebo for 12 weeks. Anxiety symptomatology was assessed using HAM-A, BAI, and STAI, while inflammatory and metabolic parameters were evaluated at baseline and post intervention. OLE supplementation was associated with a significant reduction in HAM-A scores, particularly psychic anxiety symptoms, together with lower TNF-α levels compared with placebo at the end of the intervention. No significant differences were observed in body composition, caloric intake, IL-6, hs-CRP, cortisol, or most metabolic parameters. Correlation analyses revealed positive associations between inflammatory markers, fat mass, and anxiety related measures. These findings provide preliminary evidence suggesting that OLE supplementation may exert beneficial effects on psychic anxiety symptomatology and inflammatory activity in women with excess weight. However, larger randomized clinical trials are necessary to confirm these observations and clarify the underlying mechanisms.
- 18 May 2026
- Published by MDPI AG in Preprints.org
Open AccessEffects of Olive Leaf Extract on Anxiety Symptoms and Metainflammation in Women with Excess Weight: A Randomized Double-Blind Placebo Controlled Pilot Trial
Anxiety symptomatology and excess weight are associated with chronic low-grade inflammation. Olive Leaf Extract (OLE) contains polyphenols with antioxidant and anti-inflammatory properties that have shown anxiolytic like effects in experimental models; however, evidence in humans remains limited. This randomized double-blind placebo-controlled pilot trial evaluated the effects of OLE supplementation on anxiety symptomatology, inflammatory markers, and metabolic parameters in women with excess weight and mild to moderate anxiety symptoms. Participants received OLE (750 mg/day) or placebo for 12 weeks. Anxiety symptomatology was assessed using HAM-A, BAI, and STAI, while inflammatory and metabolic parameters were evaluated at baseline and post intervention. OLE supplementation was associated with a significant reduction in HAM-A scores, particularly psychic anxiety symptoms, together with lower TNF-α levels compared with placebo at the end of the intervention. No significant differences were observed in body composition, caloric intake, IL-6, hs-CRP, cortisol, or most metabolic parameters. Correlation analyses revealed positive associations between inflammatory markers, fat mass, and anxiety related measures. These findings provide preliminary evidence suggesting that OLE supplementation may exert beneficial effects on psychic anxiety symptomatology and inflammatory activity in women with excess weight. However, larger randomized clinical trials are necessary to confirm these observations and clarify the underlying mechanisms.